Share on StockTwits

BioDelivery Sciences International (NASDAQ:BDSI) shares reached a new 52-week high on Monday , American Banking News reports. The company traded as high as $14.44 and last traded at $14.07, with a volume of 688,753 shares changing hands. The stock had previously closed at $13.82.

A number of research firms have recently commented on BDSI. Analysts at Roth Capital raised their price target on shares of BioDelivery Sciences International to $20.00 in a research note on Friday, August 8th. Separately, analysts at Ladenburg Thalmann raised their price target on shares of BioDelivery Sciences International to $21.00 in a research note on Wednesday, July 9th. They now have a “buy” rating on the stock. One equities research analyst has rated the stock with a sell rating and four have given a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $20.50.

The stock has a 50-day moving average of $13.13 and a 200-day moving average of $10.26. The company’s market cap is $702.5 million.

BioDelivery Sciences International (NASDAQ:BDSI) last released its earnings data on Friday, August 15th. The company reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by $0.07. On average, analysts predict that BioDelivery Sciences International will post $-0.67 earnings per share for the current fiscal year.

BioDelivery Sciences International, Inc (NASDAQ:BDSI) is a specialty pharmaceutical company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.